ROCHE GLYCART

roche-glycart-logo

Roche Glycart develops antibody drug candidates, which include GA101, a humanized anti-CD20 monoclonal antibody to increase direct- and immune-mediated target cell death; and GA201, a humanized glycoengineered antibody for solid tumors.

#SimilarOrganizations #People #Financial #Website #More

ROCHE GLYCART

Social Links:

Industry:
Biotechnology Health Care Medical

Founded:
2000-01-01

Address:
Schlieren, Zurich, Switzerland

Country:
Switzerland

Website Url:
http://www.roche.ch

Total Employee:
101+

Status:
Active

Contact:
+41447556161

Total Funding:
13.6 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager Content Delivery Network Domain Not Resolving Mobile Non Scaleable Content IPv6 Google Maps


Similar Organizations

bioventix-plc-logo

Bioventix Plc

Bioventix Plc is a biotechnology company specialising in the creation and supply of high-affinity sheep monoclonal antibodies.

icos-corporation-logo

ICOS Corporation

ICOS Corporation is a biotechnology company that engages in the discovery, development, and commercialization of therapeutic products.

reset-pharmaceuticals-logo

Reset Pharmaceuticals

Reset Pharma is a biotechnology company that focuses on the development and commercialization of novel psychedelic treatments.

Founder


joel-jean-mairet_image

Joel Jean Mairet

Investors List

gilde-healthcare-partners_image

Gilde Healthcare

Gilde Healthcare investment in Series A - Roche Glycart

biomedpartners_image

BioMedPartners

BioMedPartners investment in Series A - Roche Glycart

deutsche-venture-capital_image

Deutsche Venture Capital

Deutsche Venture Capital investment in Series A - Roche Glycart

forbion-capital-partners_image

Forbion Capital Partners

Forbion Capital Partners investment in Series A - Roche Glycart

novartis-venture-fund_image

Novartis Venture Fund

Novartis Venture Fund investment in Series A - Roche Glycart

global-life-science-ventures_image

Global Life Science Ventures

Global Life Science Ventures investment in Series A - Roche Glycart

quest-capital-management-inc_image

Quest Capital Management, Inc .

Quest Capital Management, Inc . investment in Series A - Roche Glycart

Official Site Inspections

http://www.roche.ch Semrush global rank: 1.37 M Semrush visits lastest month: 20.9 K

  • Host name: 104.17.61.116
  • IP address: 104.17.61.116
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Roche Glycart" on Search Engine